Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

AIDS

Volumn 18, Issue 8, 2004, Pages 1109-1116

  Rodés, Berta ^a   Toro, Carlos ^a   Paxinos, Ellen ^b   Poveda, Eva ^a   Martinez Padial, Manuel ^a   Benito, José Miguel ^a   Jimenez, Victoria ^a   Wrin, Terri ^a   Bassani, Sylvina ^a   Soriano, Vincent ^a,c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b MONOGRAM BIOSCIENCES   (United States)

^c NONE   (Spain)

Author keywords

Disease progression; Long term non progressors; Natural history; Viral fitness

Indexed keywords

CD8 ANTIGEN; NEF PROTEIN; VIRUS RNA; VPR PROTEIN;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FOLLOW UP; GENE DELETION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; NORMAL DISTRIBUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS CARRIER; VIRUS DETECTION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GENES, NEF; GENES, VPR; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; VIRAL LOAD; VIREMIA; VIRUS REPLICATION;

EID: 2942532488     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200405210-00004     Document Type: Article

References (26)

1. Saksena N, Wang B, Dyer W. Biological and molecular mechanisms in progression and non-progression of HIV disease. AIDS Rev 2001, 3:133-144.
2. Deacon N, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker D, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995, 270:988-991.
3. Lum JJ, Cohen OJ, Nie Z, Weaver JG, Gomez TS, Yao X-J, et al. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest 2003, 111:1547-1554.
4. Yamada T, Iwamoto A. Comparison of proviral accessory genes between long-term nonprogressors and progressors of HIV type 1 infection. Arch Virol 2000, 145:1021-1027.
5. Alexander L, Weiskoptf E, Greenough T, Gaddis N, Auerbach M, Malim M, et al. Unusual polymorphisms in HIV-1 associated with nonprogressive infection. J Virol 2000, 74:4361-4376.
6. Grivel J, Margolis L. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat Med 1999, 5:344-346.
7. Samson M, Libert F, Doranz B, Rucker J, Liesnard C, Farber C, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
8. Hogan C, Hammer S. Host determinants in HIV infection and disease (part I). Ann Intern Med 2001, 134:761-776.
9. McCune JM. The dynamics of CD4 T-cell depletion in HIV disease. Nature 2001, 410:974-979.
10. Migueles S, Sabbaghian M, Shupert W, Bettinotti M, Marincola F, Martino L, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000, 97:2709-2714.
11. Hogan C, Hammer S. Host determinants in HIV infection and disease (part II). Ann Intern Med 2001, 134:978-996.
12. Birch M, Learmont J, Dyer W, Deacon N, Zaunders J, Saksena N, Cunningham A, et al. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol 2001, 22:263-270.
13. Greenough T, Sullivan J, Desrosiers R. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med 1999, 340:236-237.
14. Wang B, Spira T, Owen S, Lal R, Saksena N. HIV-1 strains from a cohort of American subjects reveal the presences of a V2 region extension unique to slow progressors and non-progressors. AIDS 2000, 14:213-223.
15. Deeks S, Wrin T, Liegler T, Hoh R, Hayden M, Barbour J, et al. Virologic and immunologic consequences of discontinuing combination antiretroviral drug therapy in HIV-infected patients with detectable viremia. N Engl J Med 2001, 344:472-480.
16. Kirchhoff F, Easterbrook P, Douglas N, Troop M, Greenough T, Weber J, et al. Sequence variations in HIV type 1 Nef are associated with different stages of disease. J Virol 1999, 73:7752-7764.
17. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen O, Demarest J, et al. Studies in subjects with long-term nonprogressive HIV infection. N Engl J Med 1995, 332:209-216.
18. Candotti D, Costagliola D, Joberty C, Bonduelle O, Rouzioux C, Autran B, et al. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. J Med Virol 1999, 58:256-263.
19. Silvestri G, Feinberg M. Turnover of lymphocytes and conceptual paradigms in HIV infection. J Clin Invest 2003, 112:821-824.
20. Migueles S, Laborico A, Shupert W, Sabbaghian MS, Rabin R, Hallahan C, et al. HIV-specific CD8+T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nature 2002, 3:1061-1068.
21. Blaak H, van't Wout A, Brouwer M, Hooibrink B, Hovenkamp E, Schuitemaker H. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci USA 2000, 97:1269-1274.
22. Xiao L, Rudolph D, Owen S, Spira T, Lal R. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 1998, 12:F137-F143.
23. Mulherin S, O'Brien T, Ioannidis J, Goedert J, Buchbinder S, Coutinho R, et al. Effects of CCR5-D32 and CCR2-641 alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS 2003, 17:377-387.
24. Schonning K, Joost M, Gram G, Machuca R, Nielsen C, Nielsen J, et al. Chemokine receptor polymorphism and autologous neutralizing antibody response in long-term HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:195-202.
25. Mariani R, Kirchhoff F, Greenough T, Sullivan J, Desrosiers R, Skowronski J. High frequency of defective Nef alleles in a long-term survivor with nonprogressive HIV type 1 infection. J Virol 1996, 70:7752-7764.
26. Rhodes D, Ashton L, Solomon A, Carr A, Cooper D, Kaldor J, et al. Characterization of three Nef-defective HIV type 1 strains associated with long-term nonprogression. J Virol 2000, 74:10581-10588.